Boris Labar

4.3k total citations
146 papers, 2.1k citations indexed

About

Boris Labar is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Boris Labar has authored 146 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Hematology, 38 papers in Oncology and 35 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Boris Labar's work include Hematopoietic Stem Cell Transplantation (52 papers), Acute Myeloid Leukemia Research (42 papers) and Acute Lymphoblastic Leukemia research (33 papers). Boris Labar is often cited by papers focused on Hematopoietic Stem Cell Transplantation (52 papers), Acute Myeloid Leukemia Research (42 papers) and Acute Lymphoblastic Leukemia research (33 papers). Boris Labar collaborates with scholars based in Croatia, Netherlands and Germany. Boris Labar's co-authors include Stefan Suciu, Petra Muus, Mirando Mršić, Igor Aurer, Théo de Witte, Ivo Radman, Liliana Baila, Dominik Selleslag, Dan Nemet and Helmut R. Salih and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Boris Labar

134 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Labar Croatia 24 1.4k 713 572 416 397 146 2.1k
Mathilde Hunault France 27 1.3k 0.9× 507 0.7× 632 1.1× 653 1.6× 519 1.3× 111 2.2k
Louis Letendre United States 25 1.1k 0.8× 338 0.5× 563 1.0× 294 0.7× 490 1.2× 76 2.1k
Görgün Akpek United States 25 1.1k 0.8× 403 0.6× 465 0.8× 205 0.5× 399 1.0× 65 2.0k
Gunnar Öberg Sweden 27 1.3k 0.9× 319 0.4× 453 0.8× 279 0.7× 484 1.2× 59 2.1k
Jean‐Pierre Jouet France 17 1.5k 1.1× 286 0.4× 443 0.8× 379 0.9× 340 0.9× 39 1.9k
Donna L. Forrest Canada 27 1.4k 1.0× 422 0.6× 482 0.8× 292 0.7× 737 1.9× 110 2.3k
Selim Corbacioglu Germany 29 1.4k 0.9× 527 0.7× 643 1.1× 389 0.9× 428 1.1× 105 2.7k
Roger H. Herzig United States 22 898 0.6× 363 0.5× 696 1.2× 236 0.6× 537 1.4× 58 2.2k
G. L. Phillips Canada 20 931 0.6× 265 0.4× 507 0.9× 366 0.9× 325 0.8× 47 1.6k
Betül Oran United States 30 2.3k 1.6× 623 0.9× 606 1.1× 702 1.7× 558 1.4× 173 2.9k

Countries citing papers authored by Boris Labar

Since Specialization
Citations

This map shows the geographic impact of Boris Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Labar more than expected).

Fields of papers citing papers by Boris Labar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Labar. The network helps show where Boris Labar may publish in the future.

Co-authorship network of co-authors of Boris Labar

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Labar. A scholar is included among the top collaborators of Boris Labar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Labar. Boris Labar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Labar, Boris, et al.. (2010). DIJAGNOSTIČKO-TERAPIJSKI PRISTUP U BOLESNIKA S ESENCIJALNOM TROMBOCITEMIJOM Smjernice Hrvatske kooperativne grupe za hematološke bolesti – KROHEM. University of Zagreb University Computing Centre (SRCE). 132. 0–0.
3.
Mršić, Mirando, Boris Labar, Nadira Duraković, et al.. (2009). Dvadeset godina liječenja teške aplastične anemije u Zavodu za hematologiju Klinike za unutrašnje bolesti Kliničkog bolničkog centra Zagreb. 63. 209–214. 1 indexed citations
4.
Ludwig, Heinz, Roman Hájek, Elena Tóthová, et al.. (2008). Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma. Blood. 113(15). 3435–3442. 148 indexed citations
5.
Aljurf, Mahmoud, Syed Ziauddin A. Zaidi, Hassan El Solh, et al.. (2008). Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transplantation. 43(1). 1–12. 27 indexed citations
6.
Batinić, Drago, et al.. (2008). Biological features and outcome of biphenotypic acute leukemia. Hematology/Oncology and Stem Cell Therapy. 1(4). 225–230. 7 indexed citations
7.
Dai, Hui, Ivo Radman, Boris Labar, et al.. (2006). The Value of F-18 FDG Triple-Head Coincidence PET in the Posttreatment Evaluation of Patients With Lymphoma. Clinical Nuclear Medicine. 31(5). 275–278. 2 indexed citations
8.
Grubić, Zorana, et al.. (2005). Bone marrow transplantation- searching for hla compatible donor. Genes and Immunity. 6. 1 indexed citations
9.
Gratwohl, Aloïs, Helen Baldomero, Boris Labar, Jane F. Apperley, & Álvaro Urbano-Ispizúa. (2004). Evolution of hematopoietic stem cell transplantation in Eastern and Western Europe from 1990 to 2003. A report from the EBMT activity survey.. PubMed. 45(6). 689–94. 15 indexed citations
10.
Mršić, Mirando, Ana Stavljenić-Rukavina, Ksenija Fumić, et al.. (2003). Management of Gaucher disease in a post-communist transitional health care system: Croatian experience.. PubMed. 44(5). 606–9. 3 indexed citations
11.
Nemet, Damir, Ivo Radman, Igor Aurer, et al.. (2003). High-Dose Ifosfamide and Mitoxantrone (HDIM) as Cytoreductive and Mobilisation Protocol for Relapsed and Refractory Lymphoma. Blood. 1 indexed citations
12.
Sučić, Mirna, Renata Zadro, Boris Labar, et al.. (2002). Acute Promyelocytic Leukemia M3: Cytomorphologic, Immunophenotypic, Cytogenetic, and Molecular Variants. Journal of Hematotherapy & Stem Cell Research. 11(6). 941–950. 23 indexed citations
13.
Bašić-Kes, Vanja, Nikolina Bašić‐Jukić, Petar Kes, Vida Demarin, & Boris Labar. (2002). Neurološke posljedice koštaniš promjena pri multiplom mijelomu i njihovo liječenje. 56(3). 103–107. 1 indexed citations
14.
Suciu, Stefan, T de Witte, Franco Mandelli, et al.. (2002). Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial. Bone Marrow Transplantation. 29. 2 indexed citations
15.
Suciu, Stefan, R Zittoun, Franco Mandelli, et al.. (2001). Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial. Blood. 98(11). 5 indexed citations
16.
Mršić, Mirando, et al.. (2001). Trastuzumab in the treatment of advanced breast cancer: Single-center experience. Annals of Oncology. 12. S95–S96. 3 indexed citations
17.
Witte, T. de, R Zittoun, L Resegotti, et al.. (2000). The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial.. Blood. 96(11). 5 indexed citations
18.
Sučić, Mirna, Branka Užarević, Renata Zadro, et al.. (1999). Double Immunoenzymatic APAAP Staining for the Detection of Leukemia-Associated Immunophenotypes. Journal of Hematotherapy & Stem Cell Research. 8(6). 635–643. 3 indexed citations
19.
Francetić, Igor, et al.. (1989). Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.. PubMed. 4 Suppl 3. 105–105. 7 indexed citations
20.
Nemet, Dan, Boris Labar, Tatjana Kolevska, et al.. (1989). [Treatment of neoplastic hematologic diseases with intensive radio-chemotherapy and transplantation of cryopreserved autologous bone marrow].. PubMed. 111(9-10). 348–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026